FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER AAA ENDOPROSTHESIS
MDR report key: 2973957
·
Received February 14, 2013
Report
- Report Number
- 2017233-2013-00074
- Event Type
- Injury
- Date Received
- February 14, 2013
- Date of Event
- December 4, 2012
- Report Date
- January 18, 2013
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AZ, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
RESULTS: A REVIEW OF THE MANUFACTURING RECORDS FOR THE DEVICE VERIFIED THAT THE LOT MET ALL PRE-RELEASE SPECIFICATIONS. CONCLUSIONS: PER THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE (IFU), ADVERSE EVENTS THAT MAY OCCUR AND/OR REQUIRE INTERVENTION INCLUDE, BUT ARE NOT LIMITED TO ENDOLEAK.
Description of Event or Problem · 1
ON (B)(6) 2012, THE PATIENT WAS IMPLANTED WITH TWO GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON (B)(6) 2012, CT SCAN DETECTED A PROXIMAL TYPE I ENDOLEAK. IT IS UNKNOWN WHETHER ANEURYSM ENLARGEMENT WAS PRESENT. ON (B)(6) 2012, THE PATIENT WAS IMPLANTED WITH AN AORTIC EXTENDER COMPONENT TO TREAT THE PROXIMAL TYPE I ENDOLEAK. THE ENDOLEAK WAS RESOLVED, AND THE PATIENT TOLERATED THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 66162 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH | W.L. GORE & ASSOCIATES | 9732477 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 84 YR | Hospitalization| R | METFORMIN| WARFARIN| ATENOLOL| ASPIRIN |